You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Bayer AG in Consumer Health

Jun 2011

Price: $525

About this Report

About this Report

Euromonitor International's report on Bayer AG delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Bayer AG, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Bayer AG This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Bayer AG provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

  • Scope of the Report

Strategic Evaluation

Key company facts

  • Strategic Evaluation

Bayer sees strong growth in consumer care

  • Strategic Evaluation

SWOT – Bayer AG

  • Strategic Evaluation

Key strategic objectives and challenges

  • Strategic Evaluation

Competitive Positioning

Acquisitions help to boost sales earlier in review period

  • Competitive Positioning

Consumer health remains highly fragmented

  • Competitive Positioning

Heritage in aspirin – future across OTC

  • Competitive Positioning

Asia Pacific to lead regional growth in consumer health

  • Competitive Positioning

Geographic Opportunities

Western Europe remains crucial for Bayer

  • Geographic Opportunities

Analgesics and VDS prevalent for Bayer in North America

  • Geographic Opportunities

VDS growth in North America to dwarf all other categories

  • Geographic Opportunities

VDS will heavily influence Bayer’s prospects

  • Geographic Opportunities

Product Opportunities

Outlook for ibuprofen strong but weak Bayer presence

  • Product Opportunities

Naproxen – focus on arthritis benefits

  • Product Opportunities

USA and China emerge as strongest opportunities

  • Product Opportunities

Exposure to slow growth in Western Europe

  • Product Opportunities

Expand in dietary supplements

  • Product Opportunities

Rennie returns to growth

  • Product Opportunities

China to lead indigestion and heartburn remedies

  • Product Opportunities

Geographic presence restricts growth

  • Product Opportunities

Invest in China to compete with J&J’s Daktarin

  • Product Opportunities

One-child policy drives emergency contraception in China

  • Product Opportunities

Brand and Private Label Strategy

Bayer more than just aspirin

  • Brand and Private Label Strategy

Bayer more than just aspirin

  • Brand and Private Label Strategy

Alka-Seltzer must look beyond North America

  • Brand and Private Label Strategy

Supradyn reliance on Western Europe

  • Brand and Private Label Strategy

Operations

Global production network

  • Operations

Recommendations

Key recommendations

  • Recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?